SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Vascular Solutions LLC VASC NASDAQ

NASDAQ • Healthcare • Medical - Devices • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Vascular Solutions LLC (VASC) 是一家 Medical - Devices 公司，属于医疗保健行业, 目前交易价格为 $56.00. 其SharesGrow评分为 61/100, 表明高于平均的投资特征， 7项中通过3项.

财务数据: 营收为 $147M, +14.4%/yr 平均增长. 净利润为 $10M, 增长率为 +3%/yr. 净利润率为 7.1% (较薄). 毛利率为 66.8% (-0.1 pp 趋势).

资产负债表: 总债务为 $4M 对比 $128M 股东权益 (D/E比率 0.03, 保守). 流动比率为 5.23 (流动性强). 资产负债率为 2.5%. 总资产: $145M.

SharesGrow 7项标准细分: Value 15/100 (Fail), Growth 63/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 54/100 (Partial), Future ?/100 (Fail), Income 45/100 (Partial).

VASC SharesGrow 评分概览

63/100

SharesGrow Score

Above average fundamentals

View full scorecard →

价值 15/100

估值 — P/E, PEG, Forward PEG

成长 63/100

财务数据 — 平均增长

过去 100/100

强劲 — 趋势

健康 100/100

资产负债表 — D/E比率, 流动比率为

护城河 54/100

毛利率为 + market cap

未來 0/100

分析师展望 — 为买入

收入 45/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — VASC

VASC 市盈率(P/E)为 N/A (S&P 500平均约25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上涨空间 (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

VASC: +14.4%/yr 营收为, +3%/yr 净利润为平均增长. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

VASC: 4 / 4 年盈利. 强劲 — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

资产负债表 VASC: D/E比率 0.03 (保守), 流动比率为 5.23 (流动性强). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

护城河 Partial

VASC: 毛利率为 66.8% (-0.1 pp 趋势), N/A market cap. Moat (0-100): margin (35%) + 趋势 (15%) + market cap (30%) + 营收为 (20%). Score 54/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

VASC: 净利润率为 7.1%. 较薄 (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间57.15-25.06

成交量1.21M

30日平均成交量157.96K

Beta（1年）1.06

股份统计

EPS（TTM）0.61

流通股数$17.1M

IPO日期2000-07-20

财务亮点与比率

营收（TTM）$147.2M

毛利润$98.3M

EBITDA$19.64M

净利润$10.46M

营业利润$13.6M

现金总额$41.49M

总负债$3.63M

净负债$-37.87M

总资产$144.87M

市盈率（P/E）91.8

分析师预测

公司信息

交易所NASDAQ

货币USD

股价走势

VASC

Vascular Solutions LLC · NASDAQ

Healthcare • Medical - Devices

其他人也在看

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言